GT200500366A - Tiazolidinonas metasustituidas, su preparacion y su uso como medicamento - Google Patents

Tiazolidinonas metasustituidas, su preparacion y su uso como medicamento

Info

Publication number
GT200500366A
GT200500366A GT200500366A GT200500366A GT200500366A GT 200500366 A GT200500366 A GT 200500366A GT 200500366 A GT200500366 A GT 200500366A GT 200500366 A GT200500366 A GT 200500366A GT 200500366 A GT200500366 A GT 200500366A
Authority
GT
Guatemala
Prior art keywords
thiazolidinones
preparation
metas
replaced
medicinal product
Prior art date
Application number
GT200500366A
Other languages
English (en)
Inventor
Volker Schulze
Knut Eis
Lars Wortmann
Dirk Kosemund
Olaf Prien
Gerhard Siemeister
Holger Hess-Stumpe
Uwe Eberspaecher
Dominic E A Brittain
Imadul Islam
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35895206&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GT200500366(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE102004061503A external-priority patent/DE102004061503A1/de
Application filed filed Critical
Publication of GT200500366A publication Critical patent/GT200500366A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

LA INVENCION SE RELACIONA CON TIAZOLIDINONAS DE LA FORMULA GENERAL (I) Y A SU PREPARACION Y UTILIZACION COMO INHIBIDORES DE LA POLOQUINASA (PLK) PARA EL TRATAMIENTO DE ENFERMEDADES PROLIFERATIVAS.
GT200500366A 2004-12-15 2005-12-13 Tiazolidinonas metasustituidas, su preparacion y su uso como medicamento GT200500366A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004061503A DE102004061503A1 (de) 2004-12-15 2004-12-15 Metasubstituierte Thiazolidinone, deren Herstellung und Verwendung als Arzneimittel
US63777704P 2004-12-22 2004-12-22

Publications (1)

Publication Number Publication Date
GT200500366A true GT200500366A (es) 2006-12-04

Family

ID=35895206

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200500366A GT200500366A (es) 2004-12-15 2005-12-13 Tiazolidinonas metasustituidas, su preparacion y su uso como medicamento

Country Status (18)

Country Link
US (2) US20070015759A1 (es)
EP (1) EP1824834A1 (es)
JP (1) JP2008524139A (es)
KR (1) KR20070092740A (es)
AR (1) AR055698A1 (es)
AU (1) AU2005315835A1 (es)
BR (1) BRPI0519040A2 (es)
CA (1) CA2590396A1 (es)
CR (1) CR9183A (es)
GT (1) GT200500366A (es)
IL (1) IL183395A0 (es)
MX (1) MX2007007245A (es)
NO (1) NO20073631L (es)
PA (1) PA8656501A1 (es)
PE (1) PE20061157A1 (es)
TW (1) TW200628458A (es)
UY (1) UY29264A1 (es)
WO (1) WO2006063806A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005005395A1 (de) * 2005-02-03 2006-08-10 Schering Aktiengesellschaft Thiazolidinone, deren Herstellung und Verwendung als Arzneimittel
CA2641219A1 (en) * 2006-01-31 2007-08-09 Elan Pharmaceuticals, Inc. Alpha-synuclein kinase
EP2247748A2 (en) * 2008-02-13 2010-11-10 Elan Pharma International Limited Alpha-synuclein kinase
EP2141163A1 (de) * 2008-07-02 2010-01-06 Bayer Schering Pharma AG Substituierte Thiazolidinone, deren Herstellung und Verwendung als Arzneimittel
JP5578705B2 (ja) * 2010-03-29 2014-08-27 公益財団法人相模中央化学研究所 （アリール）ジフルオロ酢酸エステル誘導体及びその製造方法
WO2014069434A1 (ja) * 2012-10-30 2014-05-08 カルナバイオサイエンス株式会社 新規チアゾリジノン誘導体
BR112015024073A2 (pt) * 2013-03-20 2018-05-08 Bayer Pharma AG Derivados de 3-acetilamino-1-(fenil-heteroaril- aminocarbonil ou fenil-heteroarilcarbonilamino) benzeno para tratamento de doenças hiperproliferativas
US20160052898A1 (en) * 2013-03-20 2016-02-25 Bayer Pharma Aktiengesellschaft Novel compounds
WO2015116696A1 (en) 2014-01-28 2015-08-06 Massachusetts Institute Of Technology Combination therapies and methods of use thereof for treating cancer
TN2016000550A1 (en) * 2014-06-16 2018-04-04 Centre Hospitalier Regional Univ De Lille Chru Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases
WO2023158514A1 (en) 2022-02-18 2023-08-24 Massachusetts Institute Of Technology Cancer treatment by combined inhibition of polo-like kinase and microtubule polymerization

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005538048A (ja) * 2002-05-03 2005-12-15 シエーリング アクチエンゲゼルシャフト チアゾリジノン類、それらの生成及び医薬剤としての使用
DE10351744A1 (de) * 2003-10-31 2005-06-16 Schering Ag Thiazolidinone, deren Herstellung und Verwendung als Arzneimittel

Also Published As

Publication number Publication date
UY29264A1 (es) 2006-06-30
KR20070092740A (ko) 2007-09-13
AR055698A1 (es) 2007-09-05
NO20073631L (no) 2007-09-12
JP2008524139A (ja) 2008-07-10
US20070015759A1 (en) 2007-01-18
CR9183A (es) 2008-01-21
IL183395A0 (en) 2007-09-20
PE20061157A1 (es) 2006-11-16
AU2005315835A1 (en) 2006-06-22
EP1824834A1 (de) 2007-08-29
US20100048891A1 (en) 2010-02-25
TW200628458A (en) 2006-08-16
WO2006063806A1 (de) 2006-06-22
BRPI0519040A2 (pt) 2009-01-13
CA2590396A1 (en) 2006-06-22
MX2007007245A (es) 2008-02-25
PA8656501A1 (es) 2006-09-08

Similar Documents

Publication Publication Date Title
GT200500366A (es) Tiazolidinonas metasustituidas, su preparacion y su uso como medicamento
GT200500363A (es) 3-amino-pirazol [3,4b] piridinas con inhibidores de proteintirosinquinasas, su preparacion y uso como medicamento.
PA8772101A1 (es) Imidazol-triazolopirimidinas sustituidas
ECSP11011113A (es) Piridiloxi-indoles inhibidores del vegf-r2 y uso de los mismos para el tratamiento de enfermedades
SV2009003299A (es) Derivados de dihidropiridina de utilidad como inhibidores de la proteina quinasa
ECSP077235A (es) Benzamidas sustituidas por trifluoro-metilo como inhibidores de quinasa
UY31484A1 (es) Piperidinas heteroaril-sustituidas
BRPI0721905B8 (pt) composto inibidor de proteassoma, sua composição farmacêutica e seu uso
CR10489A (es) Derivados fenil-pirazol como ligandos de receptores glucocorticoides no esteroides
HN2010001920A (es) Dihidropirazolonas sustituidas como inhibidores de hif- propil-4-hidroxilasa
GT200900230A (es) 4-aril-1,4-dihidro-1,6-naftiridinamidas sustituidas y uso
MA32200B1 (fr) Nouvelles formulations,comprimes comprenant de telles formulations, leur utilisation et leur procede de preparation
UY29099A1 (es) Fenilaminotiazoles sustituidos y su uso
PA8661701A1 (es) Tiazolidinonas, su preparacion y su uso como medicamento
HN2011001019A (es) Derivados de anilina-pirimidina sustituidos con sulfoximina como inhibidores de quinasas dependientes de ciclina (cdk) produccion y uso de los mismos como productos medicinales
DK2243772T3 (da) Hidtil ukendte P2X7R-antagonister og deres anvendelse
CO6630193A2 (es) Inhibidores de la actividad de la proteína tirosina quinasa seleccionada
UY31133A1 (es) "oxazolidinonas sustituidas y su uso"
SV2006002290A (es) Nonadepsipeptidos acilados ii ref. bhc041327-sv
BR112015023878A2 (pt) composto, composição farmacêutica, e, uso de um composto
ATE496899T1 (de) Tetrahydro- und dihydrochinazolinone
DOP2005000256A (es) Tiazolidinonas metasustituidas, su preparacion y su uso como medicamento
AR075783A1 (es) Peptido para el tratamiento profilactico o terapeutico de tumores de la piel en estadios iniciales
CR9323A (es) TIAZOLIDINONAS COMO INHIBIDORAS DE LAS POLOQUINASAS (Plk) COMO MEDICAMENTO
CR7866A (es) Pirimidinas inhibidoras de chk, pdk y akt, su produccion y su uso como agentes farmaceuticos